封面
市場調查報告書
商品編碼
1616685

腹腔鏡器材市場機會、成長動力、產業趨勢分析與預測 2024 - 2032

Laparoscopic Instruments Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2024 - 2032

出版日期: | 出版商: Global Market Insights Inc. | 英文 152 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2023年,全球腹腔鏡器械市場估值為143億美元,預計2024年至2032年間複合年成長率為9.1%。推動。對這些手術技術日益成長的需求推動了市場的擴張,這些技術具有縮短恢復時間和最小化疤痕等優點。隨著肥胖和相關健康問題的日益流行,減重手術顯著成長。此外,胃腸道疾病和癌症等慢性病的發生率不斷上升,增加了對腹腔鏡手術的需求,從而增強了現代手術實踐中對創新器械的需求。

腹腔鏡器械是微創手術中使用的重要工具,在微創手術中會形成小切口,並使用攝影機指導外科醫生。該技術可在對周圍組織造成最小損傷的情況下進行精確手術,從而提高患者的治療效果。該市場按產品類型細分,腹腔鏡在 2023 年處於領先地位,收入約為 57 億美元。腹腔鏡對於在手術過程中提供視覺清晰度至關重要,並用於各種專業,包括普通外科、婦科、泌尿科和減肥科,這有助於其在市場上佔據主導地位。

從應用程式來看,2023年一般外科細分市場佔多數佔有率,收入達54億美元。此細分市場涵蓋闌尾切除術、疝氣修補和胃腸手術等眾多手術,由於腹腔鏡器械的廣泛使用,推動了對腹腔鏡器械的巨大需求。一般外科手術中微創技術的採用進一步增加了對這些工具的需求。在使用方面,一次性器材在 2023 年以 52.6% 的收入佔有率引領市場。

市場範圍
開始年份 2023年
預測年份 2024-2032
起始值 143 億美元
預測值 320 億美元
複合年成長率 9.1%

按最終用途分類,醫院佔據市場主導地位,貢獻了 97 億美元的收入。醫院需要進行各種複雜的手術,需要先進的設備並處理大量的患者,這增加了對腹腔鏡器械的需求。從地區來看,由於慢性病發病率高和對微創手術的偏好,北美在 2023 年的收入將達到 65 億美元。在強大的醫療基礎設施和有利的報銷政策的支持下,美國市場預計將大幅成長。

目錄

第 1 章:方法與範圍

第 2 章:執行摘要

第 3 章:產業洞察

  • 產業生態系統分析
  • 產業影響力
    • 成長動力
      • 腹腔鏡手術器械的技術進步
      • 微創手術日益受到青睞
      • 腹腔鏡手術數量不斷增加
      • 強大的產品管線
    • 產業陷阱與挑戰
      • 設備成本高
      • 嚴格規定
  • 成長潛力分析
  • 技術景觀
  • 監管環境
  • 未來市場趨勢
  • 報銷場景
  • 差距分析
    • 美國
    • 加拿大
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 義大利
    • 中國
    • 日本
    • 印度
  • 波特的分析
  • PESTEL分析

第 4 章:競爭格局

  • 介紹
  • 公司市佔率分析
  • 公司矩陣分析
  • 主要市場參與者的競爭分析
  • 戰略定位矩陣
  • 戰略儀表板

第 5 章:市場估計與預測:按產品分類,2021 - 2032 年

  • 主要趨勢
  • 腹腔鏡
    • 視訊腹腔鏡
    • 纖維腹腔鏡
  • 能源設備
  • 氣腹機
  • 抽吸系統
  • 封閉裝置
  • 手用儀器
  • 存取裝置
  • 腹腔鏡配件

第 6 章:市場估計與預測:按應用分類,2021 - 2032

  • 主要趨勢
  • 婦科手術
  • 泌尿科
  • 大腸直腸手術
  • 減重手術
  • 一般外科
  • 小兒外科
  • 其他應用

第 7 章:市場估計與預測:按用途分類,2021 - 2032 年

  • 主要趨勢
  • 一次性的
  • 可重複使用的

第 8 章:市場估計與預測:按最終用途,2021 - 2032 年

  • 主要趨勢
  • 醫院
  • 門診手術中心

第 9 章:市場估計與預測:按地區分類,2021 - 2032 年

  • 主要趨勢
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 義大利
    • 荷蘭
    • 歐洲其他地區
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 韓國
    • 亞太地區其他地區
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 拉丁美洲其他地區
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 中東和非洲其他地區

第 10 章:公司簡介

  • Aesculap, Inc. (B. Braun)
  • Apollo Endosurgery
  • Boston Scientific Corporation
  • CONMED Corporation
  • Cook Medical Inc.
  • Ethicon Inc. (Johnson & Johnson)
  • Intuitive Surgical
  • Karl Storz GmbH
  • Medtronic Plc (Covidien)
  • Microline Surgical
  • Olympus Corporation
  • Richard Wolf GmbH
  • Smith & Nephew Inc.
  • Stryker Corporation
簡介目錄
Product Code: 1954

The Global Laparoscopic Instruments Market was valued at USD 14.3 billion in 2023 and is projected to grow at a CAGR of 9.1% between 2024 and 2032. This growth is primarily driven by the rising number of laparoscopic procedures and the increasing preference for minimally invasive surgeries. The market's expansion is fueled by the growing need for these surgical techniques, which offer benefits like reduced recovery time and minimal scarring. With the increasing prevalence of obesity and related health issues, bariatric surgeries have seen significant growth. Furthermore, the rising occurrence of chronic conditions such as gastrointestinal disorders and cancers has heightened the need for laparoscopic surgeries, reinforcing the demand for innovative instruments in modern surgical practices.

Laparoscopic instruments are essential tools used in minimally invasive surgeries, where small incisions are made, and a camera is used to guide the surgeon. This technique allows for precise operations with minimal damage to surrounding tissues, enhancing patient outcomes. The market is segmented by product type, with laparoscopes leading in 2023 with a revenue of around USD 5.7 billion. Laparoscopes are vital in providing visual clarity during surgeries and are used across various specialties, including general surgery, gynecology, urology, and bariatrics, contributing to their dominance in the market.

By application, the general surgery segment held the majority share in 2023, generating USD 5.4 billion in revenue. This segment covers numerous procedures like appendectomies, hernia repairs, and gastrointestinal surgeries, driving significant demand for laparoscopic instruments due to their widespread use. The adoption of minimally invasive techniques in general surgery further boosts the demand for these tools. In terms of usage, disposable instruments led the market with a 52.6% revenue share in 2023. Disposable tools offer the advantage of reducing the risk of cross-contamination, ensuring compliance with strict sterility standards in healthcare settings.

Market Scope
Start Year2023
Forecast Year2024-2032
Start Value$14.3 Billion
Forecast Value$32 Billion
CAGR9.1%

By end-use, hospitals dominated the market, contributing USD 9.7 billion in revenue. Hospitals cater to a wide range of complex surgeries, demanding advanced equipment and handling a higher volume of patients, which fuels the need for laparoscopic instruments. Regionally, North America accounted for USD 6.5 billion in revenue in 2023, driven by a high incidence of chronic diseases and a preference for minimally invasive surgeries. The U.S. market is projected to grow significantly, supported by a robust healthcare infrastructure and favorable reimbursement policies.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market scope & definitions
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Base estimates & calculations
    • 1.3.1 Base year calculation
    • 1.3.2 Key trends for market estimation
  • 1.4 Forecast model
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
    • 1.5.2 Data mining sources

Chapter 2 Executive Summary

  • 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Technological advancements in laparoscopic surgical instruments
      • 3.2.1.2 Growing preference for minimally invasive surgery
      • 3.2.1.3 Increasing number of laparoscopic procedures
      • 3.2.1.4 Strong product pipeline
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 High cost of the devices
      • 3.2.2.2 Stringent regulations
  • 3.3 Growth potential analysis
  • 3.4 Technology landscape
  • 3.5 Regulatory landscape
  • 3.6 Future market trends
  • 3.7 Reimbursement scenario
  • 3.8 Gap analysis
  • 3.9 Number of gynecological laparoscopic procedures by 10 major markets, 2021 - 2032
    • 3.9.1 U.S.
    • 3.9.2 Canada
    • 3.9.3 Germany
    • 3.9.4 UK
    • 3.9.5 France
    • 3.9.6 Spain
    • 3.9.7 Italy
    • 3.9.8 China
    • 3.9.9 Japan
    • 3.9.10 India
  • 3.10 Porter's analysis
  • 3.11 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

  • 4.1 Introduction
  • 4.2 Company market share analysis
  • 4.3 Company matrix analysis
  • 4.4 Competitive analysis of major market players
  • 4.5 Strategic positioning matrix
  • 4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product, 2021 - 2032 ($ Mn)

  • 5.1 Key trends
  • 5.2 Laparoscopes
    • 5.2.1 Video laparoscopes
    • 5.2.2 Fiber laparoscopes
  • 5.3 Energy devices
  • 5.4 Insufflators
  • 5.5 Suction systems
  • 5.6 Closure devices
  • 5.7 Hand instruments
  • 5.8 Access devices
  • 5.9 Laparoscopic accessories

Chapter 6 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn and Procedures)

  • 6.1 Key trends
  • 6.2 Gynecological surgery
  • 6.3 Urological surgery
  • 6.4 Colorectal surgery
  • 6.5 Bariatric surgery
  • 6.6 General surgery
  • 6.7 Pediatric surgery
  • 6.8 Other applications

Chapter 7 Market Estimates and Forecast, By Usage, 2021 - 2032 ($ Mn)

  • 7.1 Key trends
  • 7.2 Disposable
  • 7.3 Reusable

Chapter 8 Market Estimates and Forecast, By End-use, 2021 - 2032 ($ Mn)

  • 8.1 Key trends
  • 8.2 Hospitals
  • 8.3 Ambulatory surgical centers

Chapter 9 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

  • 9.1 Key trends
  • 9.2 North America
    • 9.2.1 U.S.
    • 9.2.2 Canada
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 France
    • 9.3.4 Spain
    • 9.3.5 Italy
    • 9.3.6 Netherlands
    • 9.3.7 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 China
    • 9.4.2 Japan
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 South Korea
    • 9.4.6 Rest of Asia Pacific
  • 9.5 Latin America
    • 9.5.1 Brazil
    • 9.5.2 Mexico
    • 9.5.3 Argentina
    • 9.5.4 Rest of Latin America
  • 9.6 Middle East and Africa
    • 9.6.1 South Africa
    • 9.6.2 Saudi Arabia
    • 9.6.3 UAE
    • 9.6.4 Rest of Middle East and Africa

Chapter 10 Company Profiles

  • 10.1 Aesculap, Inc. (B. Braun)
  • 10.2 Apollo Endosurgery
  • 10.3 Boston Scientific Corporation
  • 10.4 CONMED Corporation
  • 10.5 Cook Medical Inc.
  • 10.6 Ethicon Inc. (Johnson & Johnson)
  • 10.7 Intuitive Surgical
  • 10.8 Karl Storz GmbH
  • 10.9 Medtronic Plc (Covidien)
  • 10.10 Microline Surgical
  • 10.11 Olympus Corporation
  • 10.12 Richard Wolf GmbH
  • 10.13 Smith & Nephew Inc.
  • 10.14 Stryker Corporation